Key Laboratory of Natural Resources and Functional Molecules of the Changbai Mountain, Affiliated Ministry of Education, Yanbian University College of Pharmacy, Yanji, P.R. China.
Arch Pharm (Weinheim). 2011 Oct;344(10):689-95. doi: 10.1002/ardp.201100005. Epub 2011 Sep 2.
36 Novel heterocyclic chalcone derivatives were synthesized and tested for their anti-bacterial activity. Some compounds presented good anti-microbial activities against Gram-positive bacteria (including the multidrug-resistant clinical isolates). This class of compounds presented high potency against Streptococcus mutans, among which the derivatives F2 with an MIC of 2 µg/mL was as active as the standard drug (norfloxacin) and less active than oxacillin. All the compounds did not inhibit the growth of Gram-negative bacteria (Escherichia coli CCARM 1924 or Escherichia coli CCARM 1356) at 64 µg/mL.
合成了 36 种新型杂环查尔酮衍生物,并测试了它们的抗菌活性。一些化合物对革兰氏阳性菌(包括多药耐药的临床分离株)表现出良好的抗菌活性。这一类化合物对变异链球菌具有很高的活性,其中衍生物 F2 的 MIC 为 2μg/ml,与标准药物(诺氟沙星)活性相当,低于苯唑西林。所有化合物在 64μg/ml 时均不抑制革兰氏阴性菌(大肠杆菌 CCARM 1924 或大肠杆菌 CCARM 1356)的生长。